about
Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in ThailandEfficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapineLong-term virological outcome in children on antiretroviral therapy in the UK and Ireland.Cost-effectiveness of early infant HIV diagnosis of HIV-exposed infants and immediate antiretroviral therapy in HIV-infected children under 24 months in ThailandAn analysis of volumes, prices and pricing trends of the pediatric antiretroviral market in developing countries from 2004 to 2012.Outcomes after viral load rebound on first-line antiretroviraltreatment in children with HIV in the UK and Ireland: an observational cohort studyFive-year trends in antiretroviral usage and drug costs in HIV-infected children in ThailandImmediate antiretroviral therapy in young HIV-infected children: benefits and risks.Early infant diagnosis of HIV infection in low-income and middle-income countries: does one size fit all?Hospitalization trends, costs, and risk factors in HIV-infected children on antiretroviral therapy.Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand.Growing up with perinatal HIV: changes in clinical outcomes before and after transfer to adult care in the UK.Interventions to improve treatment, retention and survival outcomes for adolescents with perinatal HIV-1 transitioning to adult care: moving on up.Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland.Early infant HIV diagnosis and entry to HIV care cascade in Thailand: an observational study.Prevalence, incidence, and associated risk factors of tuberculosis in children with HIV living in the UK and Ireland (CHIPS): a cohort study.Incidence of Tuberculosis and Associated Mortality in a Cohort of Human Immunodeficiency Virus-Infected Children Initiating Antiretroviral Therapy.Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.Brief Report: AIDS-Defining Events and Deaths in HIV-Infected Children and Adolescents on Antiretrovirals: A 14-Year Study in Thailand.The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.Lipoatrophy/lipohypertrophy outcomes after antiretroviral therapy switch in children in the UK/Ireland.Simulation Modeling and Metamodeling to Inform National and International HIV Policies for Children and AdolescentsGender and access to HIV testing and antiretroviral treatments in Thailand: Why do women have more and earlier access?Characterizing the double-sided cascade of care for adolescents living with HIV transitioning to adulthood across Southern AfricaOutcomes in children on raltegravir: a story of two halvesReview article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation - implications for maternal dosing, foetal exposure, and safety for mother and childThe cascade of care for children and adolescents with HIV in the UK and Ireland, 2010 to 2016
P50
Q28535141-9928DE87-BBE1-4D37-929E-76469EFC8586Q34071112-E2DAB4A1-2A65-4267-953B-162FEF3508E7Q34410947-49230BAB-6FD6-427F-B3A7-1A5C76E5357FQ35121725-C3D51475-2542-4FFA-84D5-EED53845D845Q35958603-CEEB5E74-112C-4639-8400-A76F8DC6CA6BQ36087922-48E5028B-B1A1-4F76-92FF-1001845A928BQ37098285-AC0938FF-3A45-4B9B-9638-96FD62D5E6C8Q37403284-FC01F383-F0FE-4B6C-B168-C8BE4C24B2A4Q38181250-D71DDA4A-BE96-4898-B4AB-6FF7F67030E5Q38431314-287FAF34-A8F0-4C44-8763-3465289AC5C0Q38434698-6FB437AC-69A8-4F5E-888B-5DB68C55A8C9Q38771852-35B3B616-D524-4331-A9C0-6E1869AC51D3Q38858111-E10C0AE5-10F7-41A5-8512-E62A3FB28B6AQ38886429-0E5AECDF-D6ED-4ACF-AE98-6DE9F347443DQ39725376-6D063105-177F-42EA-B6C8-D6161D8893B2Q40266142-1EBC0504-2BBF-4CA0-9C93-2FFE2C397C5CQ40330798-09178424-9967-4293-9FCB-BB6385589233Q47547900-C82696ED-AD7A-4250-8170-4909CA0F3259Q47777733-2E6E01F1-2278-4B77-9430-D2E94CC30921Q51365567-E6E0589B-78FF-4D75-B821-89502AAFE5F1Q53695978-2863F775-88EC-4943-89F8-C20D3C09823EQ57169257-5B34AC4E-16CF-4229-974F-64366C5209F6Q60915943-A55EE151-14AF-493A-ACCC-3150B6FF3202Q89461859-91BA1ED7-3BE0-46A3-A1FE-42CA3476EB9CQ90346135-EAED6F90-F524-48E0-B548-B3FED034ACDCQ92861354-6ECD4BB1-6EAD-4655-9C8F-6FC8299B9029Q93195039-ED1CB24A-684B-47C6-9252-AC1D8E9E0D0C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Intira J Collins
@ast
Intira J Collins
@en
Intira J Collins
@es
Intira J Collins
@nl
type
label
Intira J Collins
@ast
Intira J Collins
@en
Intira J Collins
@es
Intira J Collins
@nl
prefLabel
Intira J Collins
@ast
Intira J Collins
@en
Intira J Collins
@es
Intira J Collins
@nl
P106
P1153
33867508100
P21
P31
P496
0000-0003-2132-6037